Publisher DOI: 10.1016/j.soard.2018.02.029
Title: Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner
Language: English
Authors: Riedel, Nina 
Laubner, Katharina 
Lautenbach, Anne 
Schön, Gerhard 
Schlensak, Matthias 
Stengel, Rainer 
Eberl, Thomas 
Dederichs, Frank 
Aberle, Jens 
Seufert, Jochen 
Issue Date: Jun-2018
Journal or Series Name: Surgery for Obesity and Related Diseases 
Volume: 14
Issue: 6
Startpage: 769
Endpage: 779
Abstract: 
Abstract

Background: The endoscopic duodenal-jejunal bypass liner (DJBL) represents a novel temporary endoscopic approach for treatment of obesity-associated type 2 diabetes. Recent results from the German DJBL registry confirmed substantial positive metabolic effects of the DJBL in type 2 diabetes. However, the last Food and Drug Administration trial was stopped due to a high occurrence of hepatic abscesses (3.5%).

Objectives: Here, we analyzed time courses of development of co-morbidities, nutritive changes, and occurrence of adverse events during the 1-year treatment phase with the DJBL in the German DJBL registry.

Methods: Sixty-six patients from the registry were analyzed for efficacy, safety, and nutritional status. Patient data sets were analyzed at implantation, 3 and 6 months after implantation, and at explantation visits.

Results: Weight, body mass index, glycated hemoglobin, and low-density lipoprotein cholesterol primarily declined during the first 3 months after implantation, whereas systolic and diastolic blood pressure were predominantly reduced during the second half of the treatment phase. Severe DJBL-associated side effects were mainly documented at the explantation visit (intestinal obstruction [1.7%], dislocation [1.7%], and liver abscess [1.7%]). Measurements of serum concentrations of ferritin, albumin, vitamin B12, folic acid, 25-hydroxyvitamin D3 (25 OH-Vit-D3), and calcium provided suggestive evidence of a possible decrease of nutritional absorption of vitamins and trace elements by the DJBL.

Conclusions: The DJBL demonstrates high efficacy with substantial improvement of all parameters of the metabolic syndrome and the potential for reduction of comedications in overweight patients with type 2 diabetes. These registry results are important to optimize recommendations for adaptation of concomitant medication, surveillance of adverse events, nutritional status and supplementation, and adaptation of the implantation period of the DJBL.

[Epub 2018 Mar 9]
URI: http://hdl.handle.net/20.500.12738/4567
Institute: Department Ökotrophologie 
Fakultät Life Sciences 
Type: Article
Appears in Collections:Publications without full text

Show full item record

Page view(s)

77
checked on Dec 26, 2024

Google ScholarTM

Check

HAW Katalog

Check

Add Files to Item

Note about this record


Items in REPOSIT are protected by copyright, with all rights reserved, unless otherwise indicated.